A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

The social profile of reluctant responders is even more worrying: this attitude was more prevalent among low-income people (37%), who are generally more exposed to infectious diseases,4 among young women (aged 18–35 years; 36%), who play a crucial role regarding childhood vaccination,5 and among peo...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 20; no. 7; pp. 769 - 770
Main Authors Peretti-Watel, Patrick, Seror, Valérie, Cortaredona, Sébastien, Launay, Odile, Raude, Jocelyn, Verger, Pierrea, Fressard, Lisa, Beck, François, Legleye, Stéphane, L'Haridon, Olivier, Léger, Damien, Ward, Jeremy Keith
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.07.2020
Elsevier Limited
New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001
Subjects
Online AccessGet full text
ISSN1473-3099
1474-4457
1474-4457
DOI10.1016/S1473-3099(20)30426-6

Cover

More Information
Summary:The social profile of reluctant responders is even more worrying: this attitude was more prevalent among low-income people (37%), who are generally more exposed to infectious diseases,4 among young women (aged 18–35 years; 36%), who play a crucial role regarding childhood vaccination,5 and among people aged older than 75 years (22%), who are probably at an increased risk for severe illness from COVID-19. When this dimension has been studied, researchers have often found a connection between political beliefs and attitudes to vaccines.6 They highlight a crucial issue for public health interventions: how can we assure the public that recommendations reflect the state of scientific knowledge rather than political interests? Public authorities are setting up fast-track approval processes for a putative vaccine against SARS-CoV-2.9 It is crucial to communicate early and transparently on these processes to avoid vaccines becoming part of political debates.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMCID: PMC7239623
The COCONEL Group includes: Patrick Peretti-Watel (scientific coordinator), Valérie Seror, Sébastien Cortaredona, Odile Launay, Jocelyn Raude, Pierre Verger (research consortium), François Beck, Stéphane Legleye, Olivier L'Haridon, Jeremy Ward (steering committee)
Aix Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France (PP-W, VS, SC, JW); Southeastern Health Regional Observatory (ORS Paca), Marseille, France (PP-W, PV); Inserm CIC 1417, Université Paris, Faculté de Médecine Paris Descartes, AP-HP, Hôpital Cochin, Paris, France (OL); EHESP School of Public Health, Rennes, France (JR); CESP, Université Paris Sud, Faculté de Médecine UVSQ, Inserm, Université Paris-Saclay, Villejuif, France (FB, SL); Université Rennes, CNRS, CREM UMR 6211, Rennes, France (OL'H); and GEMASS, CNRS, Université Paris Sorbonne, Paris, France (JW)
ISSN:1473-3099
1474-4457
1474-4457
DOI:10.1016/S1473-3099(20)30426-6